Dr. Matthew Hardwick

Dr. Matthew Hardwick, CEO and founder of ResInnova Laboratories, is a thought leader in the field of infection prevention in the healthcare environment of care and is an expert in antimicrobial surface technologies. He has 20 years of academic research experience, at Georgetown University where he completed his PhD in Cell Biology, and at Johns Hopkins University, where he completed 2 postdoctoral fellowships, one in the Bloomberg School of Public Health and the second in the James Buchanan Brady Urological Institute. His last academic appointment was with the MedStar Health Research Institute where he worked on numerous research initiatives including the use of antimicrobial surfaces in clinical healthcare environments. He is widely published, including several articles on the use of antimicrobials in clinical environments and the role of microbial surface contamination on infection rates in clinical settings. He is the current chair of the RA31 AATCC committee on Antimicrobial Activity Test Methods and is active in the ASTM E35.15 subcommittee on Antimicrobial Agents.